US Food and Drug Administration Approval of Biologic Drugs for Use in Children and Adolescents

This cohort study assesses pediatric labeling patterns and use of US Food and Drug Administration–approved therapeutic drugs in the US from 1965 to 2024.

Authors

Institutions

Publication Details

Journal
JAMA Pediatrics
Published
2025-12-08
DOI
https://doi.org/10.1001/jamapediatrics.2025.5087
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

US Food and Drug Administration Approval of Biologic Drugs for Use in Children and Adolescents

Sebastian Schneeweiß, Florence T. Bourgeois, Timothy J. Savage, Ning Lyu
JAMA Pediatrics
Pharmaceutical studies and practices
article

US Food and Drug Administration Approval of Biologic Drugs for Use in Children and Adolescents

Sebastian Schneeweiß, Florence T. Bourgeois, Timothy J. Savage, Ning Lyu
article en

Abstract

This cohort study assesses pediatric labeling patterns and use of US Food and Drug Administration–approved therapeutic drugs in the US from 1965 to 2024.

JAMA PediatricsVol. 180(2)
Brigham and Women's Hospital (US), Harvard University (US)
Openalex Percentile: Top 51%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.